Residency · Residency · Interventional Radiology

Thoracic Fluid Drainage: Chest Tube and Pleural Catheter Placement

Overview

Image-guided thoracic drainage encompasses thoracentesis, small-bore chest tube placement, and tunneled pleural catheter insertion. Indications include pleural effusion, pneumothorax, empyema, and hemothorax. Performed under ultrasound and/or CT guidance with local anesthesia. Tunneled pleural catheters (e.g., PleurX) have changed the management paradigm for malignant effusions.

Pleural Effusion Evaluation

Classification

Transudative: CHF, cirrhosis, nephrotic syndrome, hypoalbuminemia. Exudative: malignancy, infection (parapneumonic/empyema), PE, autoimmune disease. Light's criteria for exudate (any one positive): Pleural protein / serum protein >0.5. Pleural LDH / serum LDH >0.6. Pleural LDH >2/3 upper limit of normal serum LDH.

Imaging Assessment

Ultrasound: first-line for pleural effusion characterization and guidance. Simple effusion: anechoic. Complex effusion: septations, debris, echogenic material. Estimates volume and identifies optimal drainage site. CT with contrast: characterizes underlying cause, identifies loculations, pleural enhancement (suggests empyema or malignancy), and lung parenchymal disease.

Thoracentesis

Technique

Diagnostic (small volume, 50-100 mL) or therapeutic (large volume, 1-2 L). Ultrasound-guided: identify deepest fluid pocket, mark site, avoid diaphragm and solid organs. Patient seated upright, leaning forward over a table. 18-gauge needle or catheter-over-needle advanced under real-time ultrasound guidance. Aspirate and send for: cell count, protein, LDH, glucose, pH, cytology, culture, Gram stain. Large-volume thoracentesis: limit to 1-1.5 L per session (re-expansion pulmonary edema risk). Use vacuum bottle drainage systems for efficiency.

Complications

Pneumothorax (2-5% without ultrasound guidance; <1% with ultrasound). Re-expansion pulmonary edema (rare, with rapid drainage of large chronic effusions). Hemorrhage (intercostal vessel injury, splenic/hepatic laceration). Vasovagal reaction.

<image>Ultrasound image showing a large left-sided pleural effusion with the diaphragm and compressed lung visible, with planned needle insertion site marked for thoracentesis</image>

Small-Bore Chest Tube Placement

Indications

Moderate to large pleural effusion requiring continuous drainage. Pneumothorax (spontaneous, iatrogenic, or traumatic). Parapneumonic effusion or empyema. Hemothorax (small-bore for minor; large-bore for significant hemothorax).

Technique

Seldinger technique under ultrasound or CT guidance. Catheter sizes: 8-14 Fr pigtail catheters (most common in IR). Access: safe triangle (anterior border of latissimus dorsi, lateral border of pectoralis major, line superior to horizontal level of nipple, apex of axilla). Steps: Ultrasound localization of fluid/air. Local anesthesia (including intercostal periosteum). Needle insertion over the superior rib margin (avoid intercostal neurovascular bundle on inferior margin). Aspirate fluid/air to confirm position. Advance guidewire, dilate, place pigtail catheter. Secure catheter; connect to underwater seal or drainage system. Confirm position with chest radiograph.

Small-Bore vs. Large-Bore

Small-bore (≤14 Fr): adequate for most effusions and pneumothoraces. BTS guidelines: small-bore catheters are first-line for most indications. Large-bore (≥20 Fr): consider for significant hemothorax, large air leaks, or thick empyema. Small-bore advantages: less pain, easier insertion, fewer complications. Small-bore limitations: may occlude with thick fluid or clot.

Empyema Management

Complicated parapneumonic effusion and empyema often require: Small-bore chest tube + intrapleural fibrinolytic therapy (tPA + DNase). MIST2 trial protocol: tPA 10 mg + DNase 5 mg instilled intrapleurally, clamped for 1 hour, then drained; twice daily for 3 days. Significantly reduces need for surgery compared with saline alone. Alternative: VATS (video-assisted thoracoscopic surgery) for multiloculated empyema. Surgical decortication for organizing empyema (fibrinopurulent or organized stage).

<image>Chest radiograph showing a small-bore pigtail chest tube in the left hemithorax with near-complete drainage of a previously large parapneumonic effusion</image>

Tunneled Pleural Catheter (TPC)

Indications

Recurrent symptomatic malignant pleural effusion. Recurrent non-malignant effusion refractory to medical therapy (hepatic hydrothorax, CHF). Trapped lung (lung cannot re-expand due to visceral pleural thickening). Patient preference for home drainage over hospitalization.

PleurX / Aspira System

Silicone catheter with a polyester cuff (promotes tissue ingrowth for securement). Tunneled subcutaneously (reduces infection risk). One-way valve prevents air entry. Drained at home by patient/caregiver using vacuum bottles. Standard drainage schedule: every 1-2 days, 500-1000 mL per session.

Placement Technique

Ultrasound localization of effusion; mark optimal insertion site. Local anesthesia to skin, subcutaneous tissue, and pleural space. Create subcutaneous tunnel (5-10 cm from entry site to pleural space). Seldinger access into pleural space; guidewire and peel-away sheath placement. Thread tunneled catheter through subcutaneous tunnel; advance through peel-away sheath into pleural space. Remove peel-away sheath; position polyester cuff within tunnel (1-2 cm from skin exit). Aspirate effusion to confirm function. Secure with suture and dressing.

Spontaneous Pleurodesis

Occurs in 40-60% of malignant effusion patients with TPC. Defined as: daily drainage <50 mL for 3 consecutive drainages. Catheter can be removed once pleurodesis confirmed. Mechanism: chronic drainage → apposition of visceral and pleural surfaces → inflammation → fibrosis. Does NOT occur in trapped lung (visceral and parietal pleura cannot appose).

Controversy: TPC vs. Chemical Pleurodesis

Chemical Pleurodesis (Talc)

Talc slurry via chest tube or talc poudrage via VATS. Success rate: 70-80% for malignant effusions. Requires hospitalization (3-7 days). Requires lung re-expansion (trapped lung is a contraindication). Complications: pain, fever, ARDS (rare with graded talc).

Tunneled Pleural Catheter

Outpatient procedure; immediate symptom relief. Effective even with trapped lung. Avoids hospitalization for pleurodesis. Catheter-related complications: infection (3-5%), catheter obstruction, dislodgement. Ongoing maintenance required (home drainage, supplies).

Current Evidence

TIME-2 trial: TPC vs. talc pleurodesis — similar dyspnea relief at 6 months; TPC had fewer hospital days. AMPLE-2 trial: TPC with daily drainage → higher pleurodesis rates. Combination approaches: TPC + talc instillation through the catheter (IPC-Plus trial showed higher pleurodesis rate). Choice depends on: lung expansion status, expected survival, patient preference, ability to manage catheter at home.

<image>Tunneled pleural catheter (PleurX) placement showing the subcutaneous tunnel with the polyester cuff positioned within the tunnel and the catheter tip in the pleural space with the external drainage connection</image>

Complications

Chest Tube / TPC

Catheter malposition. Infection (empyema from chest tube 1-2%; TPC infection 3-5%). Catheter obstruction. Intercostal vessel injury / hemorrhage. Organ injury (liver, spleen, diaphragm). Tumor seeding along catheter tract (rare). Catheter fracture or dislodgement. Subcutaneous emphysema.

Pleural-Specific

Re-expansion pulmonary edema (drain slowly; limit initial drainage). Sympathetic effusion (contralateral after pleurodesis). Loculated effusion (may require fibrinolytic therapy or additional catheter).

Clinical Pearls

Always use ultrasound guidance for thoracentesis and chest tube placement — it reduces pneumothorax risk from 5% to <1% and improves first-pass success. The intercostal neurovascular bundle runs along the inferior rib margin — always insert the needle/catheter over the superior margin of the rib. For malignant effusions, assess for trapped lung (failure to re-expand after initial drainage) — this dictates whether pleurodesis is feasible or if a tunneled catheter is the better option. The MIST2 protocol (tPA + DNase) has revolutionized empyema management — it significantly reduces surgical referrals for parapneumonic collections. Re-expansion pulmonary edema risk increases with effusions present >3 days and volumes >1.5 L drained rapidly; stop drainage if the patient develops chest tightness or cough. Tunneled pleural catheters achieve spontaneous pleurodesis in ~50% of patients — counsel patients that the catheter may be temporary rather than permanent. For hepatic hydrothorax, a tunneled pleural catheter can improve quality of life, but watch for protein and electrolyte depletion with large daily drainage volumes. When placing a chest tube for pneumothorax, aim for the apex of the hemithorax; for fluid, aim posteriorly and inferiorly.

References

• Davies HE, et al. Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Malignant Pleural Effusion (TIME2 Trial). JAMA. 2012;307(22):2383-2389.
• Rahman NM, et al. Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection (MIST2 Trial). N Engl J Med. 2011;365(6):518-526.
• Defined BTS Guidelines for Pleural Disease. Thorax. 2010;65(Suppl 2):ii54-ii60.
• Defined TJ, et al. Tunneled Pleural Catheters for Malignant Pleural Effusions: Review. J Vasc Interv Radiol. 2017;28(4):483-491.
• Thomas R, et al. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis (IPC-Plus Trial). JAMA. 2017;318(19):1903-1912.

Read this lecture as Markdown